Published - Jan 22, 2019 9:09 AM Updated: Jan 22, 2019 9:09 AM
The Chairman of GlaxoSmithKline Plc Philip Hampton has decided to quit after a stint of over three and a half years in the position, media reports said.
The news comes close to the drugmaker’s decision to split its business into one for prescription drugs and vaccines, and the other for over-the-counter products.
Chief Executive Emma Walmsley had announced in December that GSK and Pfizer have decided to join hands in their consumer health businesses.
“Following the announcement of our deal with Pfizer and the intended separation of the new consumer business, I believe this is the right moment to step down and allow a new Chair to oversee this process through to its conclusion over the next few years,” Hampton said in a statement.
Hampton had taken up the job at GSK when the company was going through a rough phase. He was given the responsibility of bringing the firm out of the crisis. Prior to GSK, Hampton was the Chairman of Royal Bank of Scotland Group Plc and J Sainsbury Plc.
For more updates, subscribe to our WhatsApp Channel - http://bit.ly/e4mWhatsApp
For more updates, subscribe to our Newsletter - http://bit.ly/2Qu7OIs
WhatsApp, Instagram, LinkedIn, Twitter, Facebook & Youtube